Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

62.71
Delayed Data
As of May 27
 +0.81 / +1.31%
Today’s Change
45.45
Today|||52-Week Range
71.60
+5.86%
Year-to-Date
Biogen & AbbVie's Multiple Sclerosis Drug Gets FDA Nod
10:00am / Zacks.com - Paid Partner Content
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Dru...
May 25 / Zacks.com - Paid Partner Content
3 Small Biotechs Make Some Noise on a Quiet Day
May 27 / TheStreet.com - Paid Partner Content
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data
May 25 / Zacks.com - Paid Partner Content
AbbVie's HUMIRA Gets EU Regulator's Positive Opinion To Treat Some Non-Infectious Uve...
May 27 / Benzinga - Paid Partner Content
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
May 25 / MotleyFool.com - Paid Partner Content
Investors Eager for Gilead to Make Big Moves
May 26 / TheStreet.com - Paid Partner Content
Remain Patient in This Sideways Market
May 24 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie
May 26 / Zacks.com - Paid Partner Content
3 Stocks With Better Dividends Than Johnson & Johnson
May 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close61.90
Today’s open61.99
Day’s range61.90 - 63.20
Volume5,768,006
Average volume (3 months)8,271,880
Market cap$101.4B
Dividend yield3.64%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+11.01%
Earnings growth (next 5 years)+14.58%
Revenue growth (last year)+14.52%
P/E ratio18.8
Price/Sales4.24
Price/Book25.59

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.34-0.79%
SNYSanofi+0.15+0.36%
NVONovo Nordisk-0.61-1.09%
AGNAllergan+3.58+1.54%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 22, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers

Search for Jobs